Skip to main content
. 2022 Feb 23;14(5):1151. doi: 10.3390/cancers14051151

Figure 3.

Figure 3

(a) Visualization in the IGV software of different ERBB2 mutations found in the primary tumor and the cutaneous metastasis in patient Pt13. (b) Orthogonal validation by the Sanger sequencing.